Position in NKTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$3,637,984
+$962,685 QoQ
Shares Held
1,285,507
+1.4% QoQ
Ownership
1.79%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 136 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. NKTX ranks #268 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in NKTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,637,984 | 1,285,507 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,675,299 | 1,267,915 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,135,497 | 1,154,323 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $2,210,976 | 1,068,105 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $2,005,906 | 1,208,378 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,204,895 | 1,198,313 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,941,578 | 1,181,357 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $5,293,036 | 1,171,026 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $6,720,254 | 1,137,099 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $8,803,750 | 814,408 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,314,684 | 653,740 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $879,490 | 632,727 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,444,044 | 659,381 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,283,345 | 643,196 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,711,913 | 619,685 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $7,896,381 | 600,029 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,665,107 | 540,999 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,893,205 | 254,236 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,049,913 | 263,838 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,839,917 | 281,910 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $9,224,166 | 291,075 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,728,064 | 326,081 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $16,359,256 | 266,134 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,731,792 | 257,212 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||